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Abstract.  We have developed procedures for detecting 
synaptic vesicle-binding proteins by using glutaralde- 
hyde-fixed or native vesicle fractions as adsorbent ma- 
trices.  Both adsorbents identify a prominent  synaptic 
vesicle-binding protein of 36 kD in rat brain synapto- 
somes and mouse brain primary cultures.  The binding 
of this protein to synaptic vesicles is competed by syn- 
aptophysin,  a major integral membrane protein of syn- 
aptic vesicles, with half-maximal  inhibition  seen be- 
tween  10  -s and  10  -7 M  synaptophysin.  Because of its 
affinity for synaptophysin, we named the 36-kD synap- 
tic vesicle-binding protein physophilin (soooa, greek 
=  bubble, vesicle; ~othos, greek =  friend).  Physophi- 
lin exhibits an isoelectric point of ,,07.8, a  Stokes ra- 
dius of 6.6 nm,  and an apparent  sedimentation co- 
efficient of 5.6 S, pointing to an oligomeric structure 
of this protein.  It is present in synaptic plasma mem- 
branes prepared from synaptosomes but not in synap- 
tic vesicles. In solubilization experiments,  physophilin 
behaves as an integral membrane protein.  Thus,  a 
putative synaptic plasma membrane protein exhibits a 
specific interaction with one of the major membrane 
proteins of synaptic vesicles. This interaction may play 
a role in docking and/or fusion of synaptic vesicles to 
the presynaptic plasma membrane. 
N 
"EUROTRANSMISSION between  a  presynaptic  nerve 
terminal and a postsynaptic target cell involves quan- 
tal discharge  of transmitter  molecules.  It is com- 
monly thought that quantal release is mechanistically  based 
on the storage of neurotransmitter in specialized organdies, 
synaptic vesicles, and on the fusion of these vesicles with the 
presynaptic plasma membrane (Reichardt  and Kelly, 1983). 
Neurotransmitter  release  is  triggered  by  depolarization- 
induced calcium influx into the nerve terminal  (Augustine et 
al., 1987). The time interval between opening ofpresynaptic 
calcium channels and postsynaptic  response lies in the range 
of a few hundred microseconds, indicating that synaptic vesi- 
cles have  to be kept in  close association with the plasma 
membrane in order to assure rapid release (Reichardt  and 
Kelly, 1983; Smith and Augustine,  1988). Indeed, many syn- 
aptic vesicles are anchored near release sites by the cyto- 
skeleton, and some appear to be directly docked to the plas- 
ma membrane (Kelly,  1988). 
The specific functions  of synaptic  vesicles,  therefore,  in- 
clude uptake and storage of neurotransmitter  (Maycox et al., 
1990), interaction  with the cytoskeleton (Walker and Agos- 
ton, 1987; Landis et al., 1988; Sfidhofet al., 1989), docking 
and fusion with the plasma membrane (Heuser et al., 1979; 
Heuser and Reese,  1981), and retrieval  into the cytoplasm 
(Ceccarelli and Hurlbut, 1980; Torri-Tarelli et al., 1987; Val- 
torta et al., 1988). Specialized vesicle proteins are likely to be 
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involved in all these processes, although protein involvement 
is often only inferred by analogy with nonneuronal  systems. 
Protein-mediated  membrane fusion has been best character- 
ized with viral spike glycoproteins (for review see Stegmann 
et al.,  1989).  The earliest event in cell fusion mediated by 
a viral  fusion protein is the sudden formation  of a narrow 
pore sharing  similarities  with  proteinaceous  ion channels 
(Spruce et al., 1989). A somewhat similar "fusion pore" has 
also been observed during exocytosis in mast cells (Brecken- 
ridge and Almers,  1987). The fusion events during  intrave- 
sicular transport in mammalian  cells require (besides other 
factors) an N-ethylmaleimide-sensitive protein, which is found 
in both membrane-bound and soluble forms (Malhotra et al., 
1988; Schatz,  1989). A specific interaction  of secretory ve- 
sicles with their fusion sites via complementary recognition 
before fusion has been initially  suggested by Palade (1975). 
A putative 51-kD docking protein for chromaffin granules of 
adrenal  medulla was identified  recently by intracellular  ap- 
plication of antibodies (Schweizer et al., 1989). Furthermore, 
based on ultrastructural data calpactin  I has been proposed 
to cross-link vesicles and plasma membranes in chromaffin 
cells (Nakata et al.,  1990). 
We have focused our attention  on synaptophysin,  one of 
the major integral membrane proteins of small clear synaptic 
vesicles (Wiedenmann  and Franke,  1985; Jahn et al.,  1985; 
for review  see Wiedenmann  and  Huttner,  1989).  Synap- 
tophysin is a hexameric  molecule composed of an N-glyco- 
sylated protein of 38 kD (Rehm et al., 1986; Thomas et al., 
1988), whose primary structure has been elucidated by eDNA 
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et al., 1987). Each 38-kD subunit spans the synaptic vesicle 
membrane four times,  with both its NH2 and COOH ter- 
mini exposed to the cytosol (Leube et al., 1987; Johnston et 
al., 1989). After reconstitution into artificial liposomes and 
fusion  with  planar  lipid  bilayers,  synaptophysin  exhibits 
voltage-dependent  channel activity in vitro (Thomas et al., 
1988). However, the in vivo function of this synaptic vesicle 
membrane  protein  is  still  obscure.  Based on biochemical 
data, in vitro reconstitution  and comparison with gap junc- 
tion proteins,  we  have  suggested  that  synaptophysin  may 
dock to a complementary protein in the presynaptic plasma 
membrane of active zones, possibly followed by formation 
of a fusion pore structure initiating neurotransmitter release 
(Thomas et al.,  1988; Thomas et al.,  1989). In this report, 
we present evidence that synaptophysin binds to a presynap- 
tic plasma membrane protein of 36 kD. The possible involve- 
ment of synaptophysin and this binding protein in the dock- 
ing process of synaptic vesicles are discussed. 
Materials and Methods 
Materials 
Materials were purchased from the following  sources:  PMSF,  aprotinin, 
pepstatin, glutaraldehyde  (grade I), Escherichia coli/~-galactosidase, bo- 
vine liver catalase, rabbit muscle lactic dehydrogenase, pig heart mitochon- 
drial malic dehydrogenase, horse heart cytochrome c, high and low molecu- 
lar weight markers, and prestained molecular weight markers were from 
Sigma  Chemical GmbH (Miinchen, FRG);  35S-methionine  (>1,000  Ci/ 
mmol sp act) and 14C-methylated proteins were from Amersham Buchler 
GmbH (Braunschweig,  FRG); Sephacryl  S-300, protein A-Sepharose CL- 
4B, Polybuffer exchanger PBE 94, Folybuffer 74, Polybuffer 96, and dextran 
blue were from Pharmacia (Freiburg,  FRG); horseradish peroxidase-con- 
jugated goat anti-mouse IgG was from Dianova (Hamburg,  FRG); alkaline 
phosphatase-conjugated goat anti-mouse and goat anti-rabbit IgG were 
from Promega Biotec (Madison,  WI);  nitrocellulose membranes (pore 
size 0.45 #m) were from Schleicher & Schuell  (Dassel,  FRG); endopro- 
teinase Lys-C,  proteinase K,  ATP,  and GTP'yS  were  from Boehringer 
Mannheim GmbH (Mannheim, FRG); and EN3HANCE  was  from New 
England Nuclear (Brannschweig,  FRG).  All other chemicals used were of 
analytical  grade. 
SubceUular Fractionations 
6-wk-old Wistar rats were obtained from Charles River Laboratories (Sulz- 
feld, FRG). Synaptosomes  were prepared from freshly dissected  rat brains 
according to the method of Wolf and Kapatos (1989). All solutions addition- 
ally contained 0.1 mM PMSF, 1 tzg/mi pepstatin, and 0.02-0.03 U/ml aproti- 
nin as protease inhibitors. The synaptosomal pellets were resuspended in PBS 
at a protein concentration of 10 mg/ml.  A cytosolic fraction was obtained 
by 10-fold dilution of the synaptosomes into 5 mM Tris-HC1, pH 7.4, fol- 
lowed by homogenization at 1,500 rpm with five strokes of a Teflon pestle. 
The hypotonic lysate  was left on ice for 30 min and then centrifuged  at 
100,000 g for 1 h. Synaptic plasma membranes were prepared from synap- 
tosomes by hypotonic lysis (without  sonication) and combined flotation- 
sedimentation  density gradient centrifugation  (Jones and Matus, 1974). The 
material banding at the 34%/28.5% (wt/vol)  sucrose interphase was col- 
lected, centrifuged at 80,000 g for 20 rain, and resuspended in 5 mM Hepes- 
NaOH,  pH 7.4,  50/~M CaC12. A mitochondrial fraction was recovered 
from the pellet of the density  gradient centrifugation (Jones and Matus, 
1974) by resuspension in 10 mM KPi,  pH 7.4,  150 mM KCI. Synaptic 
vesicles were prepared as described (Huttner et al.,  1983), except that the 
final gel filtration step was omitted.  The vesicles  were resuspended in 10 
mM KPi, pH 7.4,  150 mM KC1. Membrane fractions from rat liver were 
prepared as published by Becket et al. (1989). All subcellular fractions were 
stored in small aliquots  at -70°C until use. 
Solubilization of Subcellular Fractions 
Unless indicated otherwise,  subcellular fractions were solubilized  at 5 nag 
protein/ml in the presence of 1.875% (wt/vol) Triton X-100 and 1 M KC1 
(final concentrations) with gentle shaking for 1 h at 4°C. Insoluble material 
was removed by centrifugation at 130,000 g for 20 rain. Solubilization was 
carried out in the presence of protease inhibitors as specified  above. 
For alkaline extraction,  synaptosomes  were pelleted and taken up in 
aqueous NaOH of different pH values (Steck and Yu, 1973) at a protein con- 
centration of 5 mg/ml.  After 15 min on ice, membranes were centrifuged 
at 130000 g for 20 rain, and the supernatant was neutralized with 1 M Tris- 
HC1, pH 7.4. The pellet was washed with 10 mM KPI, pH 7.4,  150 mM 
KC1, to neutrality, resuspended to the initial volume, and solubilized by add- 
ing Triton X-100 to 1.875  % (wt/vol).  After 1 h on ice, insoluble material 
was removed by centrifugation at 130,000 g for 20 rain. 
Purification of Synaptophysin and Synaptophysin 
Fusion Protein SCY-MS2 
Synaptophysin  was purified from solubilized  rat brain synaptic vesicles by 
a  combination of chromatofocusing  and gel  exclusion  chromatography 
(Thomas et al., 1988). A bacterial fusion protein (SCY-MS2) encompassing 
the cytoplasmic carboxy-terminal  tail of synaptophysin joined to MS2 poly- 
merase was prepared as described (Knaus and Betz,  1990). 
Preparation, Fractionation, and SolubiUzation 
of  Primary Neuronal Cell Cultures 
Total brains were dissected from fetal mice (C57BL/6J or BALB/c) at days 
13 and 14 of gestation. Primary cultures of neuronal cells were prepared, 
maintained, and metabolically labeled as described by Hoch et al. (1989) 
for primary cultures of spinal cord. Specifically, cells (in 6-cm-diam culture 
dishes) were incubated after 16 d with 1 rul of methionine-free  medium con- 
taining 1 mCi [35S]methionine. After 17 h, the harvested cells were either 
solubillzed immediately or subjected to hypotonic lysis and differential cen- 
trifugation.  In the latter case, the washed cellular pellet of one culture dish 
was suspended in 1 ml of 20 raM Tris-HC1, pH 7.4, 1 mM MgCI2, 0.1 mM 
PMSE  1 ~,g/ml pepstatin, 0.02 U/m1 aprotinin. In this hypotonic buffer, 
cells were left on ice for 10 rain and then homogenized with a Teflon-glass 
homogenizer.  The homogenate was sequentially  centrifuged  at 1,000 g for 
10 rain, at 20,000 g for 20 rain, and at 130,000 g for 20 rain. The resulting 
pellets are referred to as crude nuclear fraction (1,000 g), crude membrane 
fraction (20,000 g), and crude vesicular fraction (130,000 g), respectively. 
The final  130,000-g  supernatant constituted the cytosolic  fraction.  For 
solubilization,  either the washed cell pellet of one culture dish or the various 
pellets obtained by differential centrifugation were resuspended  in 10 mM 
KPi, pH 7.4, containing 150 mM KCI and the protease inhibitors specified 
above, adjusted to 1.875% (wt/vol) Triton X-100 and 1 M KCI, and gently 
shaken for 1 h at 4°C. Insoluble material was removed from the 3SS-labeled 
extracts by centrifugntion  at 130,000 g for 20 rain. 
l~xation of Organelles 
Synaptic vesicles and mitochondria (3 nag protein/ml in 10 mM KPi, pH 
7.4,  150 mM KC1) were fixed with 2% (wt/vol) glutaraldehyde  for 3 h at 
4°C as described by Meyer and Burger (1979) for chromaflin granules.  Af- 
ter termination of the fixation reaction by 0.1  M  NI-L,C1, the organelles 
were dialyzed twice against PBS for 4 h. The fixed organelles were pelleted 
at 15,000 g for 15 rain, resuspended to a nominal protein concentration of 
3 mg/ml in PBS by using a Dounce homogenizer,  and stored at 4°C. 
Binding Assays 
Chemically fixed organelles (25 t~l)  were incubated with nonlabeled solubi- 
lized subeellular fractions (25/~1) in 10 mM KPi, pH 7.4,  150 mM KC1, 
1 mM CaC12 under shaking for 30 rain at room temperature (22°C;  final 
volume 300 ltD. A sucrose cushion (750 #1) consisting of 0.2 M sucrose, 
40 mM Hepes-NaOH, pH 7.4, 1 mM CaC12, was overlaid with sample and 
centrifuged at 15,000 g for 15 rnin at 4*C. The supernatant was carefully 
removed, and 100 t~l of gel electrophoresis sample buffer was added to the 
pellet.  The pellet was resuspended by trituration with sample buffer, while 
care was taken not to rinse the wails of the tube above the sucrose cushion. 
The  samples  were boiled for 5  rain at 950C,  shortly centrifuged  in a 
microfuge,  and the supernatant was  stored at  -20°C  until analysis  by 
SDS-PAGE. 
With native organelles,  the  following  standard procedure  was  used. 
Equal amounts of radioactivity of the solubilized  fractions from primary 
neuronal cultures were diluted into buffer containing 10 mM KPi, pH 7.4, 
150 mM KCI, 1 mM CaCI2, 5 mM MgC12 (final volume 1 ml). Taking into 
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the amount of detergent contributed  by additional compounds, Triton X-100 
was adjusted to a final concentration of 0.035% (wt/vol) in all cases. After 
addition of 60 ~g of either native synaptic vesicles or mitochondria from 
rat brain, the mixtures were incubated under shaking for 30 min at room 
temperature (22"C). Sucrose  cushions consisting of 500 td of 0.1 M su- 
crose, 40 mM Hepes-NaOH, pH 7.4,  1 m.M CaC12 were carefully overlaid 
with the samples and centrifuged at 130,000 g for 20 rain at 40C using an 
ultracentrifuge (model TL-100; Beckman Instruments Inc., Palo Alto, CA). 
The supernatant was removed with a pipette,  and the pelleted organelles 
were solub'flized by trituration in 25 #1 of gel electrophoresis sample buffer. 
Additionally, 30 #1 of gel electrophoresis sample buffer were used to rinse 
the bottom of the tube and combined with the solubilized vesicles. The sam- 
ples then were processed for SDS-PAGE as described above. 
Column Chromatography 
Chromatofoeusing on a Polybuffer exchanger PBE 94 column (1 ml) was 
performed at different pH ranges. At pH 7--4, the column was equilibrated 
with 25 mM imidazole-HCI,  pH 7.4,  0.05%  (wt/vol)  Triton X-100, and 
eluted with Polybuffer 74-HC1, pH 4.0, 0.05% (wt/vol) Triton X-100. At pH 
9-6, the column was equilibrated with 25 mM ethanolamin-CH3COOH, 
pH  9.4,  0.05%  (wt/vol)  "IYiton X-100, and eluted  with Polybuffer  96- 
CH3COOH,  pH 6.0, 0.05%  (wt/vol)  Triton X-100. Radiolabeled  fractions 
were supplemented with 0.5 mg/ml of solubilized unlabeled synaptic plasma 
membrane proteins before chromatofocusing. Ionic strength was ~0.05.  1-rnl 
fractions were collected and analyzed in the binding assay using native syn- 
aptic vesicles. 
Gel exclusion chromatography on a Sephacryl S-300 column (62 ml) was 
performed using 10 mM KPi, pH 7.4, 150 mM KC1, 0.05% (wt/vol) Triton 
X-100. The total homogenate of a primary neuronal culture (450 #i), marker 
proteins (E. coli/~-galactosidase  [6.84 nm], bovine liver catalase [5.21 ran], 
rabbit muscle lactic dehydrogenase  [4.75 nm], pig heart mitochondrial 
malic dehydrogenase  [4.32 um], horse heart cytochrome c [1.87 nm]) and 
dextran blue were applied to the column in a total volume of 1 ml. 0.88-ml 
fractions were collected and analyzed in the binding assay using native syn- 
aptic vesicles.  Marker proteins were detected by light absorption or enzy- 
matic activity. 
Sucrose Gradient Centrifugation 
Linear sucrose gradients (5-20% [wt/vol],  13 ml) were prepared in 10 mM 
Hepes-NaOH, pH 7.4, 150 mM KCI, 0.05% (wt/vol) Triton X-100. Solubi- 
lized membrane fractions from labeled primary neuronal cultures were 
diluted to 150 mM KC1, and 500/~1 was applied to each gradient and cen- 
trifuged in a rotor (model SW 40; Beckman Instruments, Inc.) at 39,000 
rpm for 18.5 h at 4°C.  840-#1 fractions were collected and analyzed in the 
binding assay using native synaptic vesicles.  Marker proteins (E. coli/3-ga- 
lactosidase [15.93 S], bovine liver catalase [11.30 S], rabbit muscle lactic 
dehydrogenase [6.95 S], pig heart mitochondrial malic dehydrogenase [4.32 
S], horse heart cytochrome c [1.80 S]) were detected in a parallel gradient 
by their light absorption or enzymatic activity. 
Electrophoretic Procedures  and Immunoblotting 
SDS-PAGE on 10% (unless indicated otherwise) gels was performed as de- 
scribed (Laemmli, 1970). Silver staining was done according to Merril et 
al. (1982).  For fluorography,  gels were treated with EN3HANCE  accord- 
ing to the manufacturer's instructions and subsequently dried for 2 h at 70"C 
under vacuum. After drying, gels were e~posed to preflashed Kodak X-Omat 
films for 1-7 d. The intensity of fluorographed  or silver-stained bands was 
quantified  by  scanning with a  Hirschmann Elscript 400  densitometer. 
Transfer of proteins to nitrocellulose membrane sheets was performed as 
described (Kyhse-Andersen,  1984). Marker proteins were visualized on the 
nitrocellulose with Ponceau S. Immunodetection of synaptophysin using ei- 
ther mAb SY38 (1 #g/ml) (Wiedenmann and Franke, 1985) or a polyclonal 
antiserum (1:240) (Knaus and Betz, 1990) was performed as described by 
Becker et al. (1989). Anti-mouse or anti-rabbit IgGs coupled to alkaline 
phosphatase (1:7,500) were used for enzymatic detection. 
Protein Determination 
Protein content of subcellniar fractions was determined by a modification 
of the l.x~vry procedure ~n et al., 1986). The concentration of purified 
synaptophysin  was estimated after SDS-PAGE by comparing the intensity 
of the silver-stained bands with those of BSA standards (Boehringer Mann- 
heim GmbH). The concentration of the latter was calibrated by measuring 
the absorption at 280 nm. The concentration of SCY-MS2 was determined 
by an enzyme-linked dot immunoassay  0Viedenmann et al.,  1988) using 
purified synaptophysin  as a standard. 
Protease Treatment of  Synaptic Vesicles 
Synaptic vesicles (75 ttg of protein) were treated in a total volume of 150 
#1 of 10 mM KPi, pH 7.4, 150 mM KC1, either with 1 U of endoproteinase 
Lys-C, or 150 #g of proteinase K, for 2 h at 37"C. After centrifugation at 
130,000 g for 20 rain at 40C, the vesicular pellets were washed twice with 
10 mM KPi, pH 7.4, 150 mM KC1, and resuspended to the initial volume. 
Aliquots were used for vesicle binding assays or SDS-PAGE. 
Phase Separation in Triton X-114 
For partitioning of proteins during Triton X-114 phase separation,  the 
modification  of Bennett et al.  (1988) of the original procedure (Bordier, 
1981) was used.  A homogenate of a labeled primary neuronal culture (50 
#i) was diluted into 1 ml of cold 1% (wt/vol) Triton X-114 in PBS (precon- 
densed three times). After phase separation at 37"C for 5 rain and eentrifu- 
gation for 1 min in a microfuge,  upper (aequeous)  and lower (detergent) 
phases were collected and brought to 1 ml with cold PBS. Equal amounts 
of radioactivity  were analyzed  in the binding assay using native synaptic 
vesicles. 
Miscellaneous Methods 
Liquid scintillation counting was performed using Ready Solv (Beckman, 
Miinchen, FRG).  IgG fractions were isolated from immune sera by using 
protein A-Sepharose CL-4B chromatography (Ey et al.,  1978). 
Results 
Synaptophysin in Chemically Fixed OrganeUes  Binds 
to a 36-kD Synaptosomal Protein 
Glutaraldehyde-fixed chromaffin granules  have been  suc- 
cessfully used to identify a granule-binding protein from the 
plasma membrane of adrenal medulla (Meyer and Burger, 
1979).  The physiological  relevance of this protein was re- 
cently demonstrated by inhibition of exocytosis after intra- 
cellular injection of specific antibodies (Schweizer et al., 
1989). To analyze interactions between synaptic vesicle pro- 
teins and other synaptosomal components, we designed an 
assay  with  glutaraldehyde-fixed synaptic  vesicles.  These 
vesicles were incubated with solubilized synaptosomes from 
rat brain.  Synaptic vesicles were  subsequently  separated 
from the synaptosomal extract by centrifugation through a 
sucrose cushion, and bound proteins were solubilized and 
subjected to  SDS-PAGE.  Control experiments  confirmed 
that proteins of the fixed vesicles were not solubilized under 
our conditions, nor were proteins of the solubilized synapto- 
somes sedimented through the sucrose cushion without fixed 
vesicles  being  added.  Furthermore,  the  binding reaction 
proved to be insensitive to the detergent Triton X-100 up to 
a concentration of 0.5 % (wt/vol) (data not shown). Nonspe- 
cific binding or binding to ubiquitous proteins was monitored 
using glutaraldehyde-fixed mitochondria from rat brain as a 
control adsorbent. Comparison of the patterns of synapto- 
somal proteins binding to fixed mitochondria and synaptic 
vesicles, respectively (Fig. 1 a, lanes 2 and 3), identified a 
prominent protein of 36 +  1 kD (n =  7) that predominantly 
bound to synaptic vesicles but not to mitochondria. 
Some residual binding to mitochondria of this protein was 
probably  caused by  contamination of our  mitochondrial 
preparation with synaptic vesicles as judged from immuno- 
blots of the synaptic vesicle marker, synaptophysin (Fig.  1 
Thomas and Betz Synaptophysin-binding  Protein  2043 Figure 1. Binding assay with glutaraldehyde-fixed  organeUes. (a) A 
detergent/salt extract of rat brain synaptosomes (lane 1) was diluted 
and incubated with glutaraldehyde-fixed  organdies.  The pattern of 
proteins  binding  to  mitochondria  (lane 2)  or  synaptic vesicles 
(lanes 3 and 4) was revealed by silver staining. Incubations were 
performed in the absence (lanes 2 and 3) or presence (lane 4) of 
purified synaptophysin added to a concentration of 2.5  x  10  -7 M. 
Arrowheads mark the position of physophilin. Molecular masses 
(in kilodaltons) of marker proteins are shown on the left. (b) Im- 
munodetection of synaptophysin in 5 #g of the mitochondfial (lane 
1) or synaptic vesicle (lane 2) fractions. Subcellular fractions were 
used for SDS-PAGE before glutaraldehyde fixation and immuno- 
blotted with mAb SY38. (c) Purity of synaptophysin (2 ttg) used for 
competition experiments. The gel was stained with silver. 
antibodies  (data  not shown).  Hence,  physophilin is  not a 
degradation product of synaptophysin. 
Synaptophysin  Embedded in Native OrganeUes Binds 
to a 36-kD Protein of  Primary Neuronal Cell Cultures 
To exclude the possibility of artificially generating binding 
sites  during  glutaraldehyde fixation,  we  also  used native 
vesicles as adsorbent to identify binding proteins.  To this 
end, primary neuronal cell cultures from embryonic mouse 
brain were labeled metabolically with [35S]methionine  and 
used as a source for synaptic vesicle-binding proteins. Be- 
fore incubation with native organelles, the detergent concen- 
tration in  the extracts of primary cultures was  diluted to 
0.035 % (wt/vol) Triton X-100, just above the critical micellar 
concentration of this  detergent.  Under this  condition, the 
solubilized membrane proteins were still  in  solution,  but 
added  synaptic  vesicle  proteins  were  not  solubilized  as 
judged from a close to quantitative (>95 %) recovery of syn- 
aptophysin in the pellet after centrifugation of the vesicles 
through a sucrose cushion. Furthermore, the protein pattern 
of synaptic vesicles and  mitochondria did  not detectably 
change under the conditions of the binding assay (data not 
shown). However, raising the concentration of Triton X-100 
to 0.1% (wt/vol) results in the solubilization of >80 % of syn- 
aptophysin  (Wiedenmann  and  Franke,  1985;  Jahn  et al., 
1985). In a solubilized crude membrane fraction from pri- 
mary  mouse  brain  cultures,  the  most  prominent  protein 
b). Note that the synaptic vesicle-binding protein of 36 kD, 
in contrast to most other synaptic vesicle- or mitochondria- 
binding proteins, was not a major component of the synap- 
tosomal extract (Fig.  1 a,  lane  1),  excluding nonspecific 
binding of an ubiquitous protein. When purified synaptophy- 
sin  (for purity,  see  Fig.  1 c)  was  added in  excess of the 
amount endogenously present in synaptic vesicles (Knaus et 
al.,  1986),  binding  of the  36-kD protein was  blocked to 
,x,90% (Fig. 1 a, lane 4). Addition of synaptophysin also in- 
hibited the vesicle binding of some other proteins, in particu- 
lar of  a synaptosomal protein of 31 kD (Fig. 1, compare lanes 
3 and 4). However, the binding of these proteins is consid- 
ered nonspecific, since all these proteins bound to mitochon- 
dria (Fig. 1 b) and represented abundant synaptosomal com- 
ponents (Fig. 1 a). Furthermore, these polypeptides were not 
detected as synaptophysin-displaceable vesicle-binding pro- 
teins when a different assay procedure was used (see below, 
and Fig. 3). We conclude that synaptophysin binds a synap- 
tosomal protein of 36 kD for which we propose the name 
"physophilin" (¢vact, greek =  bubble, vesicle; ~otkos, greek 
=  friend). 
Because of their similar molecular masses, we compared 
the sizes of synaptophysin and physophilin. Fig. 2 shows that 
these two proteins could be separated by SDS-PAGE. Fur- 
thermore, no synaptophysin immunoreactivity below its po- 
sition in synaptic vesicles was detected among the synaptic 
vesicle-binding proteins, using both mono- and polyclonal 
Figure 2.  Size comparison  of synaptophysin with  physophilin. 
(Lane 1) immunoblot of synaptic vesicles using monoclonal anti- 
body SY38; (lane 2) protein pattern of synaptic vesicles; (lane 3) 
synaptosornal  mitochondria-bindin_g  proteins; (lane 4) synaptosomal 
synaptic vesicle-binding proteins; (lane 5) purified synaptophysin 
(38 kD). The position of physophilin is indicated by an arrowhead. 
Note that in the molecular mass range of 38 kD, synaptic vesicles 
reveal a poorly resolved prominent doublet out of which the major 
upper band corresponds to synaptophysin. The samples were sepa- 
rated by SDS-PAGE and transferred to nitrocellulose (lane 1) or 
stained with silver (lanes 2-5). Molecular masses (in kilodaltons) 
of marker proteins are shown on the fight. 
The Journal of Cell Biology,  Volume I 1  I, 1990  2044 Figure 3. Binding assay with native organdies.  A total homogenate (lanes 1-3) as well as the extracts of the crude nuclear fraction 0anes 
4-6), of the crude membrane fraction (lanes 7-9), of the crude vesicular fraction (lanes I0-12), and the cytosolic fraction (lanes 13-15) 
of [35S]methionine-labeled  brain cultures were used in a binding assay with native organelles as described in Materials and Methods. The 
patterns of mitoehondria-binding proteins (lanes 1, 4, 7, 10, and 13) and synaptic vesicle-binding proteins in the absence (lanes 2, 5, 8, 
11, and 14) or presence (lanes 3, 6, 9, 12, and 15) of 9  ×  10  -8 M purified synaptophysin are shown. The dried gels were exposed for 
4 d at -70°C. The position of physophilin is indicated by arrowheads as well as by a star in lane 8. Molecular masses of 14C-methylated 
marker proteins are given on the left. The presence (+) or absence (-) of mitochondria (Mito), synaptic vesicles (SV), or synaptophysin 
(SY) in each binding assay is indicated at the bottom. 
which bound to non  fixed synaptic vesicles had a molecular 
mass of 36  +  1 kD (n  =  5) (Fig. 3, lane 8). This synaptic 
vesicle-binding protein showed almost no affinity for native 
mitochondria (Fig. 3, lane 7). Its binding to synaptic vesicles 
was blocked to about 70% by the addition of purified synap- 
tophysin to a concentration of 9  x  10  -8 M  (Fig. 3, lane 9; 
the addition of  higher amounts of  purified synaptophysin was 
not feasible because of raising the Triton X-100 concentra- 
tion above 0.035 % [wt/vol]). Obviously, the proteins of mo- 
lecular mass of 36 kD identified by our binding assays be- 
haved  in  an  identical  manner  in  rat  synaptosomes  and 
primary mouse brain cultures. Furthermore, their migration 
behavior in  SDS-PAGE was  indistinguishable  when  com- 
pared to prestained molecular weight markers that can be 
visualized  on both  silver-stained  gels  and  gels  dried  for 
fluorography (data not shown). Therefore, the synaptic ve- 
sicle-binding proteins of 36 kD seen by both approaches are 
thought to be identical,  i.e., physophilin. 
Physophilin was found only in trace amounts in both the 
cytosolic (Fig.  3, lane 14) and the crude vesicular (Fig. 3, 
lane 11) fractions. It is noteworthy that two prominent synap- 
tic vesicle-binding proteins, probably actin and tubulin, were 
greatly  enriched  in  the  cytosolic  fraction,  indicating  an 
efficient separation  of cellular components by differential 
centrifugation. Physophilin was  also seen in the crude nu- 
clear fraction (Fig. 3, lane 5) and in a total homogenate (Fig. 
3,  lane 2).  These data  suggest physophilin to  represent a 
membrane-associated protein. 
Characteristics of the 
Synaptophysin-Physophilin  Interaction 
To assess the affinity between synaptophysin and physophi- 
lin, we titrated the inhibitory effect of synaptophysin on the 
synaptic  vesicle-binding  activity  of physophilin.  Purified 
synaptophysin (see Fig.  1 c) in concentrations of up to 5.8 
×  10  -7 M  inhibited the binding of physophilin to glutar- 
aldehyde-fixed vesicles by >90% (Fig. 4). Because of limita- 
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Figure 4.  Competition of physophilin-binding by synaptophysin. 
Synaptosomal proteins or proteins of a crude membrane fraction 
of primary brain cultures were bound to glutaraldehyde-fixed  syn- 
aptic vesicles (o) or nonfixed synaptic vesicles (e), respectively,  in 
the presence of increasing concentrations of purified synaptophysin 
(SY). Inhibition was calculated by scanning silver-stained gels (o) 
or fluorograrns (e) and normalizing the intensity of the physophilin 
band to the actin band. The ratio of physophilin to actin in the ab- 
sence of purified synaptophysin  served as control. Throughout the 
gel, the actin band used for normalization showed a silver staining 
approximately constant in absolute intensity. The native molecular 
mass of purified synaptophysin was taken as 228 kD (Thomas et 
al., 1988). The concentration of  endogenous  synaptophysin  in solu- 
bilized synaptosomal or brain culture proteins was below 1  x 
10  .9 M in all assays. 
~.  o 
tions with the detergent concentration, purified synaptophy- 
sin could only be used up to 8.8  x  10  -8 M  with nontixed 
vesicles. This resulted in an ,070%  inhibition of the binding 
reaction (Fig. 4). However, both binding assays yielded com- 
parable results, indicating that the binding site for physophi- 
lin was not dramatically altered during the fixation of synap- 
tic  vesicles  with glutaraldehyde.  Half-maximal inhibition 
(ICs0) of physophilin-binding was seen at 10-8-10  -7 M syn- 
aptophysin (Fig. 4). These data show that the binding of syn- 
aptophysin to physophilin is of relatively high affinity. 
To  further  validate  the  specificity  of the  synaptophy- 
sin-physophilin interaction, a variety of other proteins and 
protein mixtures were tested for competing synaptic vesicle 
binding of physophilin. Whereas 1 x  10  -7 M synaptophysin 
resulted in an 80% inhibition (Fig. 4), bovine serum albumin 
(3  ×  10-6 M), ovalbumin (3  x  10  -6 M), immunoglobulin G 
(6  x  10  -6 M), cytochrome c (1  x  10  -5 M), hemoglobin (2 
x  10-6 M),  and  tetanus  toxin  (0.5  mg/mi)  all  had  no 
significant effect (inhibition <10%).  Furthermore, binding 
of  physophilin to synaptic vesicles was not affected by the ad- 
dition of solubilized mitochondrial proteins or solubilized 
liver membrane proteins to a concentration of 0.2 mg/ml. 
Likewise, no inhibition was observed when solubilized syn- 
aptic vesicle proteins were added to the binding assay in an 
amount that raised the endogenous synaptophysin  concentra- 
tion to maximally 1 ×  10  -8 M (data not shown). However, 
when synaptic vesicles were solubilized and applied to chro- 
matofocusing (the first step in our purification procedure for 
synaptophysin; see  Thomas  et  al.,  1988),  the  inhibitory 
effect of the resulting fractions on synaptic vesicle-binding 
of physophilin correlated with their synaptophysin content 
(Fig. 5). Some inhibition was also observed in fractions lack- 
ing synaptophysin. These effects were not very different  from 
the normal variations ('010-15 %) seen in the densitometric 
analysis of gels, in contrast to that caused by synaptophysin- 
containing fractions. However, the minor involvement of ad- 
ditional components of synaptic vesicles in the interaction 
between physophilin and these vesicles cannot be excluded 
presently. Because a variety of soluble as well as membrane 
proteins except synaptophysin showed no significant inhibi- 
tory effect, we conclude that the interaction between synap- 
tophysin and physophilin is specific. 
Since both neurotransmitter release and retrieval of synap- 
tic vesicles into the cytoplasm are calcium-dependent pro- 
cesses (Augustine et al., 1987; CeccareUi and Hurlbnt, 1980), 
a possible influence of  this cation has to be considered in any 
nerve terminal process. Initially, all our binding assays were 
performed in the presence of calcium (1 raM). Inclusion of 
calcium chelators (10 mM EGTA) in the assay buffers and 
sucrose cushions, however, showed no effect on the synaptic 
vesicle binding of physophilin to native vesicles (data not 
shown). In view of the emerging role of small GTP-binding 
proteins in vesicular transport (Barbacid, 1987; Segev et al., 
1988;  Bourne,  1988) and of the presence of a small GTP- 
binding protein, rab3, in synaptic vesicles (Mollard et al., 
1990),  the possible involvement of GTP-binding proteins in 
the association of synaptophysin with physophilin was inves- 
tigated using native synaptic vesicles. However, physophilin 
binding was not dependent on GTPTS (50 #M). Likewise, 
addition of ATP (1 raM) during the binding reaction did not 
alter the results (data not shown). 
A bacterial fusion protein, SCY-MS2, containing the cyto- 
plasmic carboxy-terminal tail of synaptophysin following its 
fourth transmembrane domain (amino acids 218-307;  see 
Knaus and Betz, 1990) was also tested for competition in our 
binding assays. Even at concentrations of 7  x  10  -7 M SCY- 
MS2, we did not detect any inhibitory effect of the fusion 
construct (Fig. 6 a).  Similarly, 5  x  10  -~ M of a synthetic 
tetrapeptide (GYGP) that contains the repeated motif of the 
cytoplasmic  tail  of  synaptophysin  (Leube  et  al.,  1987) 
showed no effect. This suggested that the carboxy-terminal 
cytoplasmic tail of synaptophysin may not be important for 
physophilin binding. Further support for this assumption is 
derived from binding assays in the presence of antisynap- 
tophysin antibodies. Monoclonal antibody SY38 (Wieden- 
mann and Franke, 1985) binds to a flexible segment in the 
center of the cytoplasmic repeat structure of synaptophysin, 
and a polyclonal antisynaptophysin serum also preferentially 
recognizes epitopes that are located in this cytoplasmic tail 
region (Knaus and Betz, 1990). None of these anti-tail anti- 
bodies blocked the binding of physophilin to synaptophysin, 
regardless of whether native or glntaraldehyde-fixed  vesicles 
were used as adsorbent (Fig. 6 c, lanes 4-6,  and data not 
shown). Furthermore, treatment of synaptic vesicles with en- 
doproteinase Lys-C resulted in the loss of the carboxy-ter- 
minal repeat structure of synaptophysin (cleavage produced 
a 27-28-kD fragment and presumably occurred at lysine res- 
idue 237 [Fig. 6 b]; other cytoplasmic lysine residues located 
close to the transmembrane segments probably are inacces- 
sible to the enzyme). Upon treatment of synaptic vesicles 
with endoproteinase Lys-C, the binding of physophilin was 
not altered. In contrast, no proteins were bound after diges- 
tion of synaptic vesicles with proteinase K (Fig. 6 c, lanes 
The Journal of Cell Biology,  Volume 111, 1990  2046 Figure 5. Fractionation of synaptic vesicle proteins. (a) Chromatofocusing of solubilized synaptic vesicles. The pH gradient (pH 6-4) is 
shown in the lower part of the figure. The elution profile of synaptophysin (51, squares) was determined by measuring the optical density 
at 492 nm in an enzyme-linked dot immunoassay (Wiedenmann et al.,  1988). Equal amounts of the neutralized fractions were tested for 
their ability to inhibit the binding of physophilin to glutaraldehyde-fixed  vesicles. Relative inhibition (circles) was determined as described 
in Fig. 4. In the binding assay with the pH 4.1 fraction, the concentration of synaptophysin was estimated to be 5 x  10  -8 M. This resulted 
in an inhibition of 45 %, in agreement with the titration data presented in Fig. 4. (b) Protein pattern of the chromatofocusing fractions 
that were used for competition. Equal amounts were subjected to SDS-PAGE and stained with silver. The pH value of each fraction is 
indicated above  the respective lane; the position of synaptophysin is marked with an arrow. Molecular masses (in kilodaltons) of marker 
proteins are shown on the right. 
1-3). Because removal of the COOH-terminal 70 amino acids 
of synaptophysin did not alter physophilin binding, we con- 
clude  that  these  residues  are  not  involved in  the  binding 
domain. 
PhysophiUn Is an Oligomeric Basic Protein 
Analysis of the sedimentation behavior of solubilized phys- 
ophilin on sucrose density gradients  indicated an apparent 
sedimentation coefficient of 5.6 S (Fig. 7). Thus, physophilin 
binds not in monomeric form to synaptophysin, but as a large 
complex.  When a  total homogenate from [35S]methionine- 
labeled brain cultures was applied to gel exclusion chroma- 
tography, the synaptic vesicle-binding activity of physophilin 
eluted at a Stokes radius of 6.56 nm (data not shown). Again, 
this indicated a large quaternary structure. Furthermore, elec- 
trophoretic  examination  of the  sedimentation  and  elution 
profiles obtained in these experiments revealed that no other 
synaptic vesicle-binding protein cofractionated  precisely with 
physophilin (Fig. 7, and data not shown), suggesting that phys- 
ophilin may be a major component of this complex. 
To  determine  the  isoelectric  point  of  physophilin,  the 
physophilin-containing fractions of a sucrose density gradient 
of solubilized crude membranes from radiolabeled brain cul- 
tures  were pooled and  applied to  chromatofocusing in the 
range ofpH 7 to pH 4. Proteins of isoelectric point within this 
range will bind to the column, whereas basic proteins will ap- 
pear in the flowthrough fractions. Physophilin was detected in 
the flowthrough by our standard binding assay with native 
synaptic vesicles (data not shown). Subsequently, these flow- 
through fractions were collected and re-applied to chromato- 
focusing in the range of pH 9 to pH 6. Elution of physophilin 
was maximal at pH 7.8 (data not shown). Thus, physophilin 
is a slightly basic protein, in contrast to synaptophysin, which 
is highly acidic (Wiedenmann and Franke, 1985;  Thomas et 
al.,  1988). 
SubceUular Localization of Physophilin 
Binding of proteins from primary brain cultures to nonfixed 
synaptic vesicles had revealed that physophilin was greatly 
enriched in a  crude membrane fraction and nearly absent 
from crude vesicular and cytosolic fractions (see Fig. 3). To 
further substantiate the subcellular localization of physophi- 
lin,  different cellular fractions from rat brain were inves- 
tigated for the presence of physophilin (Fig. 8). Physophilin 
binding was detected in synaptosomes as well as in synaptic 
plasma membranes prepared from the latter, but not in syn- 
aptic  vesicles  (Fig.  8,  compare lanes  1-3).  Furthermore, 
physophilin was not present in a cytosolic fraction (Fig. 8, 
lane 5; minor amounts of physophilin occasionally seen in 
cytosolic fractions prepared  from radiolabeled  cells  [see 
Fig. 3] probably reflected residual contamination resulting 
from a modified homogenization and centrifugation proce- 
dure).  Control experiments with rat liver membranes also 
gave negative results (Fig. 8, lane 6). Therefore, physophilin 
appears to be associated with synaptic plasma membranes. 
A series of extraction experiments was carried out to de- 
Thomas and Betz Synaptophysin-binding Protein  2047 Figure 6. The COOH-terminal tail region of synaptophysin is not involved in physophilin binding. (a) Solubilized synaptosomal proteins 
were bound to glutaraldehyde-fixed synaptic vesicles in the absence (lane 1) or presence of 7  x  10  -7 M SCY-MS2 fusion protein (lane 
2), or 5  x  10  -4 M tetrapeptide GYGP (lane 3), respectively. Vesicle-binding  proteins wore separated by 10% SDS-PAGE  and visualized 
by silver staining. The position of physophilin is indicated by an arrow; molecular masses (in kilodaltons) of marker proteins are shown 
on the left. (b) Native synaptic vesicles were incubated for 2 h at 37°C in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of en- 
doproteinase Lys-C. Aliquots were applied to 15% SDS-PAGE, transferred to nitrocellulose, and immunoreacted with mAb SY38 (lanes 
1 and 2) or with the IgG fraction of a polyclonal antisynaptophysin serum (lanes 3 and 4). Molecular masses (in kilodaltons) are shown 
on the right. After proteolytic cleavage, the SY38 epitope (between residues 269 and 289; see Knaus and Betz [1990]) is almost completely 
lost (lane 2), indicating that the cytoplasmic carboxy-terminal tail of synaptophysin has been removed. No intermediate products were 
observed at shorter times (data not shown), suggesting a single defined cleavage  site (probably lysine 237). A membrane-bound degradation 
product of ~ 27-28 kD was revealed by the polyclonal antiserum (lane 4). The weak staining seen is due to removal of the major antigenic 
epitope (see Knaus and Betz, 1990). (c) Solubilized crude membranes (lanes 1-3) or a total homogenate (lanes 4--6) from metabolically 
labeled primary neuronal cultures were analyzed for physophilin-binding activity using native synaptic vesicles as adsorbent. Incubations 
were carried out in the absence (lanes 1-4) or presence of 6 x  10  -7 M mAb SY38 (lane 5) or 6 x  10  4  M of an IgG fraction of polyclonal 
antisynaptophysin  antibodies (lane 6), respectively, after preincubation of  the vesicles with antibody for 30 min at 4°C. In case of solubilized 
crude membranes as donor fractions, vesicles had been preincubated in the absence (lanes 1, and 1') or presence of endoproteinase Lys-C 
(lane 2) or proteinase K (lane 3), followed by two washing steps. Samples were analyzed by 8% SDS-PAGE and fluorography. 14C- 
methylated marker proteins are shown in lane Z their molecular masses (in kilodaltons) are given on the right. The position of physophilin 
is indicated by arrows. 
termine the nature of  the association of  physophilin with syn- 
aptic  plasma  membranes.  The  extracts  were  tested  on 
glutaraldehyde-fixed synaptic vesicles for the  presence of 
physophilin (data not shown). High salt alone (1 M KCI) was 
unable to solubilize physophilin. This could not be attributed 
to altered binding properties of the protein since it was rou- 
tinely observed after our standard high salt/detergent extrac- 
tion (1 M KC1, 1.875%  [wt/vol] Triton X-100; see Materials 
and  Methods).  Alkaline  extraction  at  pH  10,  11,  or  12, 
known to remove peripheral membrane proteins from eryth- 
rocyte membranes (Steck and Yu,  1973), also failed to pro- 
mote solubilization of physophilin. In contrast, physophilin- 
binding  could  be  recovered  in  the  pellet  after  alkaline 
pretreatment up to pH  11,  arguing against inactivation of 
physophilin under these conditions. On the other hand, when 
Triton X-100 was solely used to extract physophilin from 
synaptic plasma membranes, efficient binding was observed 
after solubilization at detergent concentrations ~>1% (wt/vol). 
These results are consistent with physophilin being an inte- 
gral membrane protein. 
Partitioning of the proteins solubilized from a labeled pri- 
mary neuronal culture with Triton X-114 (Bordier, 1981) did 
not reveal a well-defined separation behavior of physophilin 
binding activity (data not shown). However, distribution into 
both detergent and water phases has also been reported for 
other integral membrane proteins that do not have a particu- 
larly low polarity index (Maher and Singer, 1985; Schneider 
et al.,  1985; Schmitt et al.,  1987). In conclusion, the data 
described above support the view that physophilin indeed is 
an  integral  membrane  protein  of synaptic  plasma  mem- 
branes. 
Discussion 
In this report, we have described procedures for studying the 
interaction  of synaptic  vesicles  with  solubilized  proteins 
from  various  sources.  One  method  takes  advantage  of 
glutaraldehyde-fixed vesicles  as  an  adsorbent  to  identify 
binding proteins. The fixed vesicles can be easily separated 
from the incubation mixture by centrifugation in a micro- 
fuge, thus allowing a selective solubilization of the adhering 
proteins only. The fixation procedure is similar to customary 
protocols used for sample fixation in immunoelectron mi- 
croscopy where binding of  antibodies to fixed epitopes is still 
observed. Chemically fixed chromaffin granules have previ- 
ously been used to isolate a granule-binding protein from the 
plasma membrane of adrenal medulla (Meyer and Burger, 
1979) that appears to be involved in exocytosis (Schweizer 
et al.,  1989). 
The  synaptic  vesicle binding  of proteins  depending  on 
multivalent interactions, or conformational flexibility of mo- 
bile receptor sites, may not be detected in a binding assay 
with fixed vesicles. This limitation is overcome by the use 
of nonfixed synaptic vesicles and minimal amounts of deter- 
gent just above the critical micellar concentration. In this 
case, ultracentrifugation must be used to recover  the synaptic 
The Journal of Cell Biology,  Volume 111, 1990  2048 Figure 7. Sedimentation behavior of physophilin. (a) Solubilized  crude membranes from [~SS]methionine-labeled  brain cultures were cen- 
trifuged on a 5-20% sucrose gradient, and the apparent sedimentation coefficient  of  physophilin  was determined by comparison to marker 
proteins as described in Materials and Methods. The position of  physophilin  is indicated as p36 in this graph. The gradient was fractionated 
from the bottom (left)  to the top (right). (b) A 300-#1 aliquot of  each fraction was tested for the presence of  physophilin. Gel electrophoretic 
evaluation of the binding assay using native synaptic vesicles is shown here for some of the fractions, numbered from the bottom (left) 
to the top (right).  C denotes a binding assay with the solubilized crude membranes before sedimentation. The position of physophilin 
is indicated by an arrow. Molecular masses (in kilodaltons) of marker proteins are given on the fight. The gel was exposed for 3 d. 
vesicles, and the adhering proteins labeled in order to be dis- 
tinguishable from synaptic vesicle proteins. This binding as- 
say with nonfixed vesicles certainly represents a closer ap- 
proach to the in vivo situation, although the presence of low 
detergent concentrations may render the vesicles leaky. The 
possibility that partner proteins loose their binding capacity 
upon membrane solubilization cannot however, be excluded. 
Physophilin  was  the  only  brain  protein  detected  that 
fulfilled all  of  the  following  criteria:  first,  it  could  be 
identified as a prominent vesicle-binding protein in both as- 
say systems; second, it did not bind to mitochondria; third, 
its binding to synaptic vesicles was competed by synaptophy- 
sin but not by many other proteins. Therefore, we have con- 
centrated on the characterization of this protein. It should be 
noted, however,  that the assays described here additionally 
revealed the binding to synaptic vesicles of minor compo- 
nents that remain to be analyzed. 
Previous attempts to isolate physophilin by affinity chro- 
matography using immobilized synaptophysin as a  ligand 
were unsuccessful (Thomas, L., unpublished results). Thus, 
either synaptophysin was coupled to the affinity matrix via 
its binding domains, or additional components of synaptic 
vesicles are necessary for the binding reaction. This under- 
lines the advantage of working with whole vesicles instead 
of isolated proteins as long as the molecular details of vesi- 
cle-plasma membrane interaction are not understood. 
The interaction between vesicle-bound synaptophysin and 
solubilized physophilin was only blocked by solubilized syn- 
aptophysin. A variety of other proteins including solubilized 
membrane proteins from subeellular fractions did not inter- 
fere with the synaptophysin-physophilin  binding, pointing to 
the specificity of this  interaction.  Moreover, our titration 
data show an affinity in the submicromolar range between 
synaptophysin and physophilin.  Together with the finding 
that this affinity is not influenced by calcium ions, GTP'yS, 
or ATE which often regulate short-term events, this suggests 
that in vivo the binding of synaptophysin to physophilin may 
not only be transient, but serve a more permanent interac- 
tion. In view of inherent limitations of our binding assay 
(e.g., presence of  detergent) and the possiNe existence of ad- 
ditional factors not revealed by the latter, further studies will 
be required to elucidate this point. 
Physophilin binding of synaptophysin was not affected by 
an excess of SCY-MS2 fusion protein and antisynaptophysin 
antibodies, or by endoproteinase Lys-C treatment of synaptic 
vesicles which cleaved the COOH-terminal tail of synap- 
tophysin, presumably at lysine residue 237  (Fig. 6 b).  We 
therefore suppose that the physophilin binding site is associated 
with cytoplasmic domains of synaptophysin not included in 
its characteristic carboxy-terminal repeat  structure.  Other 
synaptic vesicle proteins associated with synaptophysin could 
also contribute to physophilin binding. Interestingly, when 
amino acid substitutions between rat and Torpedo synapto- 
physin are considered, there are only 13% nonconservative 
exchanges (6 out of  46 intracellular residues) within the cyto- 
plasmic stretches preceding lysine 237, but 34% nonconser- 
vative replacements (24 out of 70 carboxy-terminal residues) 
in the remaining cytoplasmic repeat region cleaved off  by the 
endoproteinase (for substitutions and transmembrane topol- 
ogy, see Cowan et al.,  1990).  The substantially higher de- 
gree of evolutionary conservation argues for the functional 
importance of this assigned physophilin binding domain. Al- 
though the carboxy-terminal cytoplasmic tail containing the 
characteristic repeat structure appears not to be involved in 
physophilin binding, it may play a role in interactions with 
extravesicular proteins, e.g., cytoskeletal elements. Synaptic 
vesicles are known to be anchored to the cytoskeleton before 
they reach their release sites (Kelly, 1988). 
The hydrodynamic parameters of solubilized physophilin 
indicate that this 36-kD protein is part of a large complex. 
At present, we cannot exclude the presence of other subunits 
within this complex, although the 36-kD protein appeared to 
be its major component. Tentatively assuming a homo-oli- 
gomeric structure for physophilin, a number of 4 to 5 sub- 
Thomas and Betz Synaptophysin-binding Protein  2049 Figure 8.  Subeellular localization of physophilin. Synaptic plasma membranes (lane 1 ), synaptic vesicles (lane 2), synaptosomes (lanes 
3 and 4), cytosol (lane 5), and liver membranes (lane 6) were prepared, solubilized, and analyzed for the presence of physophilin using 
glutaraldehyde-fixed  synaptic vesicles (lanes 1-3, 5, and 6) or mitochondria (lane 4). The endogenous synaptophysin  concentration in the 
binding assay  with solubilized synaptic vesicle proteins (lane 1) was below 1-2  x  10  -s M. The position of physophilin is indicated by 
a double-headed arrow between lanes 2 and 3. Molecular masses (in kilodaltons) of marker proteins are given on the right. Gel bands 
were revealed by silver staining. 
units is consistent with the Stokes radius and sedimentation 
coefficient  determined here. A detailed structural analysis of 
purified physophilin awaits purification of this protein. 
Binding  activity of physophilin was  found in  synaptic 
plasma  membrane  fractions derived  from  synaptosomes. 
Because it was not detected in purified synaptic vesicle frac- 
tions, the presence of physophilin cannot be attributed to 
contamination by these vesicles. Furthermore, the solubili- 
zation data indicate that physophilin behaves as an integral 
membrane protein. Hence, this synaptophysin-binding pro- 
tein appears to be specifically located in synaptic membranes 
different from the membranes of small synaptic vesicles. Im- 
munofluorescence and immunoelectron microscopy will be 
required to show whether physophilin is indeed localized in 
the presynaptic plasmalemma or even in the plasma mem- 
brane of active zones. 
Calpactin, a widespread calcium-dependent phospholipid 
and actin-binding protein that has been described to play a 
role in exocytosis in adrenal chromaflin cells  (Ali et al., 
1989;  Nakata et al.,  1990)  possesses a  subunit of 36 kD. 
However, it appears unlikely that physophilin is identical to 
calpactin. First, the binding of calpactin to chromaffin gran- 
ules is calcium dependent (Creutz et al., 1983), whereas the 
binding of physophilin to synaptic vesicles is not. Second, 
the Stokes radius of calpactin is significantly smaller than 
that of physophilin (4.1 vs.  6.6 nm; see Gerke and Weber, 
1984).  Finally, in contrast to physophilin, calpactin can be 
solubilized by high salt extraction (Greenberg and Edelman, 
1983). 
The specific docking of secretory vesicles to the plasma 
membrane is assumed to represent a necessary step preced- 
ing exoeytosis (Bourne,  1988;  Kelly,  1988).  Physophilin 
seems to be a good candidate for mediating such docking of 
synaptic vesicles to the presynaptic plasma membrane before 
quantal release. The vesicle recognition site for physophilin 
should comprise the abundant synaptic vesicle component 
synaptophysin, but other proteins might in addition be in- 
volved. The docking process results in correct positioning of 
vesicles in the ultimate vicinity of  the release site, thus allow- 
ing neurotransmitter discharge to occur immediately upon 
stimulation. Whether the fusion process itself then is initi- 
ated by a proteinaceous fusion pore structure remains to be 
proven.  If so,  it appears  logical to  have the elements of 
specific recognition as well as fusion pore formation com- 
bined in one macromolecular complex. 
The results presented here should help in isolating phys- 
ophilin and further characterizing its localization and inter- 
action with synaptophysin. With these two components in 
hand, the model outlined above then may be experimentally 
approached. 
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